Liver dialysis device safe and effective for treating liver failure

Researchers have completed the first successful in-patient trial of liver dialysis.

The DIALIVE device, invented by researchers at UCL’s Institute for Liver and Digestive Health, was found to be safe and effective, research suggests.

According to a new study, the device is associated with substantial improvement in the severity of symptoms and organ function in a greater proportion of patients with acute-on-chronic liver failure (ACLF), when compared with patients receiving standard of care.

The next step would be a larger clinical trial, which if successful could see DIALIVE approved for clinical use within the next three years.

Read full story

Source: The Independent, 1 June 2023